TFF Pharmaceuticals to Raise $1.2M through Registered Direct Offering

Wednesday, 20 March 2024, 16:46

TFF Pharmaceuticals has revealed plans for a registered direct offering to secure $1.2M, which will be utilized for general corporate purposes and bolstering working capital. The move is expected to enhance the company's financial position and support future growth initiatives.

https://store.livarava.com/44d028a6-e6db-11ee-968c-5254a2021b2b.jpe — TFF Pharmaceuticals to Raise $1.2M through Registered Direct Offering

TFF Pharmaceuticals Announces $1.2M Registered Direct Offering

TFF Pharmaceuticals has announced a registered direct offering, aiming to raise $1.2M for working capital and general corporate purposes. The offering is expected to strengthen the company's financial position and support its strategic objectives.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.